5α-Reductase Inhibitors in Prostate Cancer: An Overview

    Neelima D. Passi
    TLDR 5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.
    The document provided an overview of the role of 5α-reductase inhibitors, specifically Finasteride and Dutasteride, in the management of prostate cancer, a common malignancy in elderly men. These inhibitors were noted for their ability to block the conversion of testosterone into dihydrotestosterone (DHT), a process implicated in the development of prostate cancer. The article discussed the biology of the prostate, the rationale behind using these inhibitors, their efficacy in preventing and treating prostate cancer, and the controversies surrounding their use.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 159 results

    Similar Research

    6 / 1000+ results